A recent article in the Aesthetic Surgery Journal (ASJ) by plastic surgeons Spero J. Theodorou, MD, Daniel Del Vecchio, MD and Christopher T. Chia, MD showcases the unique benefits of BodyTite liposuction, InMode’s minimally-invasive radiofrequency-assisted liposuction (RFAL) procedure. The publication describes how RFAL provides good results for even “Treatment Gap Patients”.
The FDA-approved BodyTite device is designed to provide internal and external lipolysis, resulting in three-dimensional remodeling and outcomes that are comparable to traditional liposuction. The ASJ article reviews the clinical application of radiofrequency energy using the BodyTite device on soft tissues during suction lipectomy, its effect on soft tissue contraction, and its use in aesthetic contouring in various clinical scenarios.
One of the main highlights of the ASJ publication is that it describes, for the first time, how BodyTite defines the treatment gap solution. The authors note that there are a large number of these ‘in between’ patients in this ‘gap’ category that their clinical picture presents as ‘not bad enough for an excisional procedure and not good enough for liposuction.’
Specifically, RFAL can provide effective contouring for patients with areas of “nonadherence” such as the arms, neck, and medial thighs. Liposuction alone will not work for these difficult areas. According to the authors, since RFAL technology is more effective and directed at fat resection, results can be achieved with an increased margin of safety since the skin can be anticipated to retract more than with manual suction-assisted lipectomy (SAL) alone.
According to the article, RFAL can deliver the best outcome for nontraditional liposuction candidates as well as liposuction candidates. With judicious patient selection and good body contouring, RFAL can produce a 3-dimensional soft tissue contraction for those who are not good candidates for liposuction alone, write the authors.
Before BodyTite was introduced, patients looking to get rid of unwanted fat did not have efficient options. Minimally-invasive procedures did not provide good skin tightening results and surgical procedures left large scars. With BodyTite, patients now have an effective minimally-invasive solution that provides superior aesthetic outcomes. Results can be seen immediately after one treatment and improve over three to six months post-treatment.
A leader in aesthetic medicine and technology, InMode Aesthetic Solutions offers a slew of minimally-invasive technologies to help men and women achieve their body contouring goals without lengthy scars or downtime. InMode’s latest offering, EmbraceRF combines two of its proprietary technologies – FaceTite and Mophenus8 – to address facial laxity with optimal, natural-looking results.
The ASJ article is the 22nd North American peer reviewed BodyTite/FaceTite publication and the first to discuss the treatment gap terminology in peer review. The publication also highlights InMode’s leadership in minimally invasive body contouring treatments.